Primary information |
---|
sequence ID | Seq_2709 |
Peptide sequence | GGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNR |
CancerPDF_ID | CancerPDF_ID691, CancerPDF_ID1338, CancerPDF_ID2425, |
PMID | 19795908,21136997,21136997 |
Protein Name | Fibrinogen alpha chain,Fibrinogen alpha,Fibrinogen alpha |
UniprotKB Entry Name | FIBA_HUMAN,FIBA_HUMAN,FIBA_HUMAN |
Fluid | Plasma,Serum,Plasma |
M/Z | 1173.16,3516.501,3516.501 |
Charge | 3,1,1 |
Mass (in Da) | NA,NA,NA |
fdr | NA,NA,NA |
Profiling Technique | LC-MS,LC-MS,LC-MS |
Peptide Identification technique | MALDI-TOF/TOF,LC-MS-MS/MS,LC-MS-MS/MS |
Quantification Technique | LC-MRM (multiple reaction monitoring),LC-ESI-MS,LC-ESI-MS |
Labelled/Label Free | Labelled,Label Free,Label Free |
FDR | less than 7%,NA,NA |
CancerPDF_ID | CancerPDF_ID691, CancerPDF_ID1338, CancerPDF_ID2425, |
p-Value | NA,NA,NA |
Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),MASCOT(v. 2.2.01) |
Length | 37,37,37 |
Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Colorectal cancer,Normal |
Database | NCBI refseq Protein Database,SwissProt Database,SwissProt Database |
Modification | NA,NA,NA |
Number of Patients | "42 normal, 28patients",30 patients and 30 healthy controls,27 healthy individuals |
Regulation | NA,NA,NA |
Validation | NA,Leave One out Cross validation,Leave One out Cross validation |
Sensitivity | NA,NA,NA |
Specificity | NA,NA,NA |
Accuracy | NA,NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | |